Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma in a Patient Treated with Cyclosporine for Actinic Reticuloid.


Journal

Case reports in dermatological medicine
ISSN: 2090-6463
Titre abrégé: Case Rep Dermatol Med
Pays: United States
ID NLM: 101591808

Informations de publication

Date de publication:
2020
Historique:
received: 10 12 2019
accepted: 04 03 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 11 4 2020
Statut: epublish

Résumé

Actinic reticuloid (AR)-a subtype of chronic actinic dermatitis-clinically and histopathologically shows lymphoma-like features. We report a male patient initially diagnosed with erythrodermic cutaneous T cell lymphoma (CTCL) who developed severe broadband photosensitivity. Clinical evaluation, histopathology, and phototesting were consistent with AR. The patient was treated with cyclosporine 150-300 mg/d. Under this therapy, he developed several times primary cutaneous anaplastic large cell lymphomas (C-ALCL) which in part tended to regress spontaneously under cyclosporine reduction. The association between cyclosporine treatment and development of C-ALCL and other CD30+ lymphoproliferative disorders has previously been reported in patients with atopic dermatitis, psoriasis, and transplant patients. In conclusion, the present case highlights the difficulties arising in the distinction between AR and CTCL and shows that long-term cyclosporine treatment may cause C-ALCL development in AR as well.

Identifiants

pubmed: 32274223
doi: 10.1155/2020/9435242
pmc: PMC7132347
doi:

Types de publication

Case Reports

Langues

eng

Pagination

9435242

Informations de copyright

Copyright © 2020 T. Gambichler et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Br J Dermatol. 2009 Mar;160(3):698-703
pubmed: 19067712
Am J Dermatopathol. 2014 Nov;36(11):875-81
pubmed: 25238449
Arch Dermatol. 2004 Apr;140(4):449-54
pubmed: 15096373
J Am Acad Dermatol. 1998 Sep;39(3):464-75
pubmed: 9738783
J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):966-71
pubmed: 2808833
Am J Dermatopathol. 1994 Oct;16(5):510-6
pubmed: 7802165
J Dtsch Dermatol Ges. 2018 Nov;16(11):1363-1364
pubmed: 30395399
Br J Dermatol. 1994 Aug;131(2):209-14
pubmed: 7917984
J Invest Dermatol. 1986 Feb;86(2):134-7
pubmed: 3528307
Acta Dermatovenerol Alp Pannonica Adriat. 2012 Sep;21(3):55-7
pubmed: 23267873
Photochem Photobiol. 2006 Jul-Aug;82(4):1097-102
pubmed: 16563026
Am J Clin Dermatol. 2009;10(3):169-80
pubmed: 19354331
Dermatology. 2003;206(4):330-3
pubmed: 12771475
Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):253
pubmed: 21393977
Nature. 1999 Feb 11;397(6719):530-4
pubmed: 10028970
Am J Transplant. 2004 Nov;4(11):1915-20
pubmed: 15476495
J Am Acad Dermatol. 2006 Apr;54(4):668-75
pubmed: 16546591
Coll Antropol. 2011 Sep;35 Suppl 2:325-9
pubmed: 22220464
J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S165-7
pubmed: 12140451
Br J Dermatol. 2003 Jul;149(1):170-3
pubmed: 12890213

Auteurs

T Gambichler (T)

Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

N Patsinakidis (N)

Division of Experimental Allergy and Immunodermatology, University of Oldenburg, Oldenburg, Germany.

L Susok (L)

Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

M H Segert (MH)

Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

M Doerler (M)

Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

Classifications MeSH